|
|
Article: MONEY BRIEFS.(MONEY)
- Article from:
- Telegram & Gazette (Worcester, MA)
- Article date:
- September 3, 2009
CopyrightCOPYRIGHT 2009 Worcester Telegram & Gazette. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
COLUMN: MONEY BRIEFS
Sepracor's sale is reported
Marlboro-based Sepracor rose the most in more than five years on the Nasdaq before trading in the stock was halted, after Nikkei English News reported the company agreed to be bought by Dainippon Sumitomo Pharma Co. of Okaka, Japan, for about $2.71 billion. Dainippon plans to make Sepracor a wholly owned subsidiary, boosting the company's lineup of central nervous system treatments and other drugs, Nikkei said. Sepracor plans to seek U.S. approval for its lurasidone schizophrenia treatment next year, and the company has a sales force of more than 1,000 that Dainippon wants to acquire, Nikkei said.
...